Role of oxidative stress in oxaliplatin-induced enteric neuropathy and colonic dysmotility in mice

British Journal of Pharmacology

Volumn 173, Issue 24, 2016, Pages 3502-3521

  McQuade, Rachel M ^a   Carbone, Simona E ^a   Stojanovska, Vanesa ^a   Rahman, Ahmed ^a   Gwynne, Rachel M ^b   Robinson, Ainsley M ^a   Goodman, Craig A ^a   Bornstein, Joel C ^b   Nurgali, Kulmira ^a  

^a VICTORIA UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CYTOCHROME C; INDUCIBLE NITRIC OXIDE SYNTHASE; N(G) NITROARGININE METHYL ESTER; NEURONAL NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; OXALIPLATIN; REACTIVE OXYGEN METABOLITE; ANTINEOPLASTIC AGENT; PLATINUM COMPLEX; SUPEROXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; COLON MOTILITY; COLORECTAL CANCER; CONTROLLED STUDY; DEPOLARIZATION; DIGESTIVE SYSTEM ELECTROPHYSIOLOGY; ENTERIC NEUROPATHY; EXCITATORY JUNCTION POTENTIAL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VIVO STUDY; INTESTINAL DYSMOTILITY; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; MUSCLE TONE; MYENTERIC PLEXUS; NEUROMUSCULAR TRANSMISSION; NEUROPATHY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; WATER CONTENT; ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED; COLON; DRUG EFFECTS; INTESTINE PSEUDOOBSTRUCTION; MALE; METABOLISM; MITOCHONDRION; PATHOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; COLON; INTESTINAL PSEUDO-OBSTRUCTION; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, INBRED BALB C; MITOCHONDRIA; ORGANOPLATINUM COMPOUNDS; OXIDATIVE STRESS; SUPEROXIDES;

EID: 84996538070     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13646     Document Type: Article

References (67)

1. Alexander SPH, Davenport AP, Kelly E, Marrion N, Peters JA, Benson HE et al. (2015a). The Concise Guide to PHARMACOLOGY 2015/16: G Protein-Coupled Receptors. Br J Pharmacol 172: 5744–5869.
2. Alexander SPH, Fabbro D, Kelly E, Marrion N, Peters JA, Benson HE et al. (2015b). The Concise Guide to PHARMACOLOGY 2015/16: Enzymes. Br J Pharmacol 172: 6024–6109.
3. André T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T et al. (2004). Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350: 2343–2351.
4. Areti A, Yerra VG, Naidu V, Kumar A (2014). Oxidative stress and nerve damage: role in chemotherapy induced peripheral neuropathy. Redox Biol 2: 289–295.
5. Beckman JS, Koppenol WH (1996). Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271: C1424–C1437.
6. Bornstein J, Costa M, Grider J (2004). Enteric motor and interneuronal circuits controlling motility. Neurogastroenterol Motil 16: 34–38.
7. Brand MD, Affourtit C, Esteves TC, Green K, Lambert AJ, Miwa S et al. (2004). Mitochondrial superoxide: production, biological effects, and activation of uncoupling proteins. Free Radic Biol Med 37: 755–767.
8. Burgess A, Vigneron S, Brioudes E, Labbé J-C, Lorca T, Castro A (2010). Loss of human Greatwall results in G2 arrest and multiple mitotic defects due to deregulation of the cyclin B-Cdc2/PP2A balance. Proc Natl Acad Sci 107: 12564–12569.
9. Carbone SE, Wattchow DA, Spencer NJ, Brookes SJ (2012). Loss of responsiveness of circular smooth muscle cells from the guinea pig ileum is associated with changes in gap junction coupling. Am J Physiol Gastrointest Liver Physiol 302: G1434–G1444.
10. Castro M, Muñoz J, Arruebo M, Murillo M, Arnal C, Bonafonte J et al. (2012). Involvement of neuronal nitric oxide synthase (nNOS) in the regulation of migrating motor complex (MMC) in sheep. Vet J 192: 352–358.
11. Chandrasekharan B, Anitha M, Blatt R, Shahnavaz N, Kooby D, Staley C et al. (2011). Colonic motor dysfunction in human diabetes is associated with enteric neuronal loss and increased oxidative stress. Neurogastroenterol Motil 23: 131–e126.
12. Curtis MJ, Bond RA, Spina D, Ahluwalia A, Alexander SP, Giembycz MA et al. (2015). Experimental design and analysis and their reporting: new guidance for publication in BJP. Br J Pharmacol 172: 3461–3471.
13. Daniel E, Haugh C, Woskowska Z, Cipris S, Jury J, Fox-Threlkeld J (1994). Role of nitric oxide-related inhibition in intestinal function: relation to vasoactive intestinal polypeptide. Am J Physiol Gastrointest Liver Physiol 266: G31–G39.
14. Daniel EE, Wang YF, Salapatek AM, Mao YK, Mori M (2000). Arginosuccinate synthetise, arginosuccinate lyase and NOS in canine gastrointestinal tract: immunocytochemical studies. Neurogastroenterol Motil 12: 317–334.
15. De Gramont A, Boni C, Navarro M, Tabernero J, Hickish T, Topham C et al. (2007). Oxaliplatin/5FU/LV in adjuvant colon cancer: updated efficacy results of the MOSAIC trial, including survival, with a median follow-up of six years. J Clin Oncol 25: 4007.
16. Denlinger CS, Barsevick AM (2009). The challenges of colorectal cancer survivorship. J Natl Compr Canc Netw 7: 883–894.
17. Di Cesare Mannelli L, Zanardelli M, Failli P, Ghelardini C (2012). Oxaliplatin-induced neuropathy: oxidative stress as pathological mechanism. Protective effect of silibinin. J Pain 13: 276–284.
18. Düssmann H, Kögel D, Rehm M, Prehn JHM (2003). Mitochondrial membrane permeabilization and superoxide production during apoptosis. A single-cell analysis. Biol Chem 278: 12645–12649.
19. Elmore S (2007). Apoptosis: a review of programmed cell death. Toxicol Pathol 35: 495–516.
20. Furness JB (2012). The enteric nervous system and neurogastroenterology. Nat Rev Gastroenterol Hepatol 9: 286–294.
21. Goodisman J, Hagrman D, Tacka KA, Souid A-K (2006). Analysis of cytotoxicities of platinum compounds. Cancer Chemother Pharmacol 57: 257–267.
22. Gottlieb E, Armour S, Harris M, Thompson C (2003). Mitochondrial membrane potential regulates matrix configuration and cytochrome c release during apoptosis. Cell Death Differ 10: 709–717.
23. Graham MA, Lockwood GF, Greenslade D, Brienza S, Bayssas M, Gamelin E (2000). Clinical pharmacokinetics of oxaliplatin: a critical review. Clin Cancer Res 6: 1205–1218.
24. Gwynne RM, Thomas E, Goh S, Sjövall H, Bornstein J (2004). Segmentation induced by intraluminal fatty acid in isolated guinea-pig duodenum and jejunum. J Physiol 556: 557–569.
25. Habiyakare B, Alsaadon H, Mathai ML, Hayes A, Zulli A (2014). Reduction of angiotensin A and alamandine vasoactivity in the rabbit model of atherogenesis: differential effects of alamandine and Ang (1-7). Int J Exp Pathol 95: 290–295.
26. Hengartner MO (2000). The biochemistry of apoptosis. Nature 407: 770–776.
27. Janes K, Doyle T, Bryant L, Esposito E, Cuzzocrea S, Ryerse J et al. (2013). Bioenergetic deficits in peripheral nerve sensory axons during chemotherapy-induced neuropathic pain resulting from peroxynitrite-mediated post-translational nitration of mitochondrial superoxide dismutase. Pain 154: 2432–2440.
28. Joseph EK, Levine JD (2009). Comparison of oxaliplatin-and cisplatin-induced painful peripheral neuropathy in the rat. J Pain 10: 534–541.
29. Kelley MR, Jiang Y, Guo C, Reed A, Meng H, Vasko MR (2014). Role of the DNA base excision repair protein, APE1 in cisplatin, oxaliplatin, or carboplatin induced sensory neuropathy. PLoS One 9: e106485.
30. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG (2010). Animal research: Reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160: 1577–1579.
31. Lecci A, Santicioli P, Maggi CA (2002). Pharmacology of transmission to gastrointestinal muscle. Curr Opin Pharmacol 2: 630–641.
32. McGrath JC, Lilley E (2015). Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP. Br J Pharmacol 172: 3189–3193.
33. McIlwain DR, Berger T, Mak TW (2013). Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol 5: a008656.
34. McQuade RM, Bornstein JC, Nurgali K (2014). Anti-colorectal cancer chemotherapy-induced diarrhoea: current treatments and side-effects. Int J Clin Med 5: 393–406.
35. McQuade RM, Stojanovska V, Donald E, Abalo R, Bornstein JC, Nurgali K (2016). Gastrointestinal dysfunction and enteric neurotoxicity following treatment with anticancer chemotherapeutic agent 5-fluorouracil. Neurogastroenterol Motil. doi:10.1111/nmo.12890.
36. Nakamura T, Lipton SA (2008). Emerging roles of S-nitrosylation in protein misfolding and neurodegenerative diseases. Antioxid Redox Signal 10: 87–102.
37. Pasinelli P, Houseweart MK, Brown RH Jr, Cleveland DW (2000). Caspase-1 and -3 are sequentially activated in motor neuron death in Cu,Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 97: 13901–13906.
38. Pini A, Garella R, Idrizaj E, Calosi L, Baccari MC, Vannucchi MG (2016). Glucagon-like peptide 2 counteracts the mucosal damage and the neuropathy induced by chronic treatment with cisplatin in the mouse gastric fundus. Neurogastroenterol Motil 28: 206–216.
39. Qu ZD, Thacker M, Castelucci P, Bagyánszki M, Epstein ML, Furness JB (2008). Immunohistochemical analysis of neuron types in the mouse small intestine. Cell Tissue Res 334: 147–161.
40. Rajagopal S, Nalli A, Kumar DP, Bhattacharya S, Hu W, Mahavadi S et al. (2015). Cytokine-induced s-nitrosylation of soluble guanylyl cyclase and expression of phosphodiesterase 1 A contribute to dysfunction of longitudinal smooth muscle relaxation. J Pharmacol Exp Ther 352: 509–518.
41. Raymond E, Faivre S, Woynarowski JM, Chaney SG (1998). Oxaliplatin: mechanism of action and antineoplastic activity. Semin Oncol 25: 4–12.
42. Renn CL, Carozzi VA, Rhee P, Gallop D, Dorsey SG, Cavaletti G (2011). Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice. Mol Pain 7: 29.
43. Rivera L, Poole D, Thacker M, Furness J (2011a). The involvement of nitric oxide synthase neurons in enteric neuropathies. Neurogastroenterol Motil 23: 980–988.
44. Rivera LR, Thacker M, Pontell L, Cho H-J, Furness JB (2011b). Deleterious effects of intestinal ischemia/reperfusion injury in the mouse enteric nervous system are associated with protein nitrosylation. Cell Tissue Res 344: 111–123.
45. Roberts JA, Durnin L, Sharkey KA, Mutafova-Yambolieva VN, Mawe GM (2013). Oxidative stress disrupts purinergic neuromuscular transmission in the inflamed colon. J Physiol 591: 3725–3737.
46. Roberts RR, Bornstein JC, Bergner AJ, Young HM (2008). Disturbances of colonic motility in mouse models of Hirschsprung's disease. Am J Physiol Gastrointest Liver Physiol 294: G996–G1008.
47. Roberts RR, Murphy JF, Young HM, Bornstein JC (2007). Development of colonic motility in the neonatal mouse-studies using spatiotemporal maps. Am J Physiol Gastrointest Liver Physiol 292: G930–G938.
48. Robinson AM, Stojanovska V, Rahman AA, McQuade RM, Senior PV, Nurgali K (2016). Effects of oxaliplatin treatment on the enteric glial cells and neurons in the mouse ileum. J Histochem Cytochem 64: 530–545.
49. Rodriguez-Membrilla A, Martinez V, Jimenez M, Gonalons E, Vergara P (1995). Is nitric oxide the final mediator regulating the migrating myoelectric complex cycle? Am J Physiol Gastrointest Liver Physiol 268: G207–G214.
50. Sarna S, Otterson M, Ryan R, Cowles V (1993). Nitric oxide regulates migrating motor complex cycling and its postprandial disruption. Am J Physiol Gastrointest Liver Physiol 265: G749–G766.
51. Savidge TC (2011). S-nitrosothiol signals in the enteric nervous system: lessons learnt from big brother. Front Neurosci 5: 31.
52. Schweizer M, Richter C (1994). Nitric oxide potently and reversibly deenergizes mitochondria at low oxygen tension. Biochem Biophys Res Commun 204: 169–175.
53. Sharma R, Tobin P, Clarke SJ (2005). Management of chemotherapy-induced nausea, vomiting, oral mucositis, and diarrhoea. Lancet Oncol 6: 93–102.
54. Slee EA, Adrain C, Martin SJ (2001). Executioner caspase-3,-6, and-7 perform distinct, non-redundant roles during the demolition phase of apoptosis. J Biol Chem 276: 7320–7326.
55. Souglakos J, Androulakis N, Syrigos K, Polyzos A, Ziras N, Athanasiadis A et al. (2006). FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG). Br J Cancer 94: 798–805.
56. Southan C, Sharman JL, Benson HE, Faccenda E, Pawson AJ, Alexander SP et al. (2016). The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. Nucl Acids Res 44: D1054–D1068.
57. Stojanovska V, Sakkal S, Nurgali K (2015). Platinum-based chemotherapy: gastrointestinal immunomodulation and enteric nervous system toxicity. Am J Physiol Gastrointest Liver Physiol 308: G223–G232.
58. Takahashi T (2003). Pathophysiological significance of neuronal nitric oxide synthase in the gastrointestinal tract. J Gastroenterol 38: 421–430.
59. Van Bergeijk J, Van Westreenen H, Adhien P, Zijlstra F (1998). Diminished nitroprusside-induced relaxation of inflamed colonic smooth muscle in mice. Mediators Inflamm 7: 283–287.
60. Vera G, Castillo M, Cabezos P, Chiarlone A, Martín M, Gori A et al. (2011). Enteric neuropathy evoked by repeated cisplatin in the rat. Neurogastroenterol Motil 23: 370–e163.
61. Verstappen CC, Heimans JJ, Hoekman K, Postma TJ (2003). Neurotoxic complications of chemotherapy in patients with cancer. Drugs 63: 1549–1563.
62. Wafai L, Taher M, Jovanovska V, Bornstein JC, Dass CR, Nurgali K (2013). Effects of oxaliplatin on mouse myenteric neurons and colonic motility. Front Neurosci 7: 30.
63. Webster RG, Brain KL, Wilson RH, Grem JL, Vincent A (2005). Oxaliplatin induces hyperexcitability at motor and autonomic neuromuscular junctions through effects on voltage-gated sodium channels. Br J Pharmacol 146: 1027–1039.
64. Wei T, Chen C, Hou J, Xin W, Mori A (2000). Nitric oxide induces oxidative stress and apoptosis in neuronal cells. Biochim Biophys Acta 1498: 72–79.
65. Yagihashi N, Kasajima H, Sugai S, Matsumoto K, Ebina Y, Morita T et al. (2000). Increased in situ expression of nitric oxide synthase in human colorectal cancer. Virchows Arch 436: 109–114.
66. Zheng H, Xiao WH, Bennett GJ (2011). Functional deficits in peripheral nerve mitochondria in rats with paclitaxel-and oxaliplatin-evoked painful peripheral neuropathy. Exp Neurol 232: 154–161.
67. Zingarelli B, O'Connor M, Hake PW (2003). Inhibitors of poly (ADP-ribose) polymerase modulate signal transduction pathways in colitis. Eur J Pharmacol 469: 183–194.